Predicate |
Object |
contentType |
Journal Article|Comment |
endingPage |
514 |
issn |
1072-7515 |
issueIdentifier |
3 |
pageRange |
512-514 |
publicationName |
Journal of the American College of Surgeons |
startingPage |
512 |
bibliographicCitation |
Premji AM, Donahue TR. Invited Commentary: Adjuvant Chemotherapy Is Beneficial in Stage III Ampullary Adenocarcinoma. J Am Coll Surg. 2023 Sep 01;237(3):512–4. doi: 10.1097/xcs.0000000000000766. PMID: 37260119. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4799f519b256d75e9f82f54ea346cca9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d749c98f507787c66de86970802dd2bf |
date |
2023-06-01^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://pubmed.ncbi.nlm.nih.gov/37260119 https://doi.org/10.1097/xcs.0000000000000766 |
isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8488 https://portal.issn.org/resource/ISSN/1072-7515 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ |
title |
Invited Commentary: Adjuvant Chemotherapy Is Beneficial in Stage III Ampullary Adenocarcinoma |
hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D003138Q000188 http://id.nlm.nih.gov/mesh/D003138Q000601 http://id.nlm.nih.gov/mesh/D014670Q000601 http://id.nlm.nih.gov/mesh/D000230Q000188 http://id.nlm.nih.gov/mesh/D000230Q000601 |
hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D009367 http://id.nlm.nih.gov/mesh/D012189 http://id.nlm.nih.gov/mesh/D017024 http://id.nlm.nih.gov/mesh/D006801 |